Do you want to read an article? Please log in or register.
Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States
Lung Cancer
RECOMMENDED
Related content
Lung Cancer
The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States
Clin Lung Cancer.
Cushman TR, Jones B, Akhavan D, Rusthoven CG, Verma V, Salgia R, Sedrak M, Massarelli E, Welsh JW, Amini A
doi: 10.1016/j.cllc.2020.09.004.
RECOMMENDED
Lung Cancer
Local ablative treatment for synchronous single organ oligometastatic lung cancer - A propensity score analysis of 180 patients
Lung Cancer.
Frost N, Tessmer A, Schmittel A, van Laak V, Raspe M, Ruwwe-Glösenkamp C, Brunn M, Senger C, Böhmer D, Ochsenreither S, Temmesfeld-Wollbrück B, Furth C, Schmidt B, Neudecker J, Rückert JC, Suttorp N, Witzenrath M, Grohé C
doi: 10.1016/j.lungcan.
RECOMMENDED
Lung Cancer
Definitive treatment patterns and survival in stage II non-small cell lung cancer
doi: 10.1016/j.lungcan.
RECOMMENDED
Lung Cancer
Institution-level differences in quality and outcomes of lung cancer resections in the United States
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Chest.
Osarogiagbon RU, Sineshaw HM, Lin CC, Jemal A
doi: 10.1016/j.chest.2020.10.075.Visit the original publication at ncbi.nlm.nih.gov
RECOMMENDED
Lung Cancer
Real-world guideline-based treatment of lung cancer improves short- and long-term outcomes and resection rate: A population-based study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer.
Helminen O, Valo J, Andersen H, Lautamäki A, Vuohelainen V, Sihvo E
doi: 10.1016/j.lungcan.2019.12.002.
RECOMMENDED
Lung Cancer
Real-World Effectiveness of Nivolumab Monotherapy After Prior Systemic Therapy in Advanced Non-Small-Cell Lung Cancer in the United States
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Clin Lung Cancer
Stenehjem DD, Lubinga SJ, Gupte-Singh K, Zhang Y, Le TK, Penrod JR, Smith CB
doi: 10.1016/j.cllc.2020.07.009
RECOMMENDED
Lung Cancer
Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line - Results from the prospective German TLK cohort study
Lung Cancer.
Steffens CC, Elender C, Hutzschenreuter U, Dille S, Binninger A, Spring L, Jänicke M, Marschner N, TLK-Group (Tumour Registry Lung Cancer)
doi: 10.1016/j.lungcan.
Lung Cancer
Understanding patients' values and preferences regarding early stage lung cancer treatment decision making
Lung Cancer.
Sullivan DR, Eden KB, Dieckmann NF, Golden SE, Vranas KC, Nugent SM, Slatore CG
doi: 10.1016/j.lungcan.2019.03.009.
COMMENTED
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
Lancet Respir Med.
Duruisseaux M, Martínez-Cardús A, Calleja-Cervantes ME, Moran S, Castro de Moura M, Davalos V, Piñeyro D, Sanchez-Cespedes M, Girard N, Brevet M, Giroux-Leprieur E, Dumenil C, Pradotto M, Bironzo P, Capelletto E, Novello S, Cortot A, Copin MC, Karachaliou N, Gonzalez-Cao M, Peralta S, Montuenga LM, Gil-Bazo I, Baraibar I, Lozano MD, Varela M, Ruffinelli JC, Palmero R, Nadal E, Moran T, Perez L, Ramos I, Xiao Q, Fernandez AF, Fraga MF, Gut M, Gut I, Teixidó C, Vilariño N, Prat A, Reguart N, Benito A, Garrido P, Barragan I, Emile JF, Rosell R, Brambilla E, Esteller M
doi: 10.1016/S2213-